The biological evaluation of novel antioestrogens for the treatment of breast cancer.
Chander
S K
SK
Department of Oncology, Celltech Limited, Slough, Berkshire, UK.
Sahota
S S
SS
Evans
T R
TR
Luqmani
Y A
YA
D001943:Breast Neoplasms / Q000188:drug therapy*; D015195:Drug Design; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000737:chemistry / Q000145:classification / Q000627:therapeutic use*; D004967:Estrogens / Q000737:chemistry; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy; D011960:Receptors, Estrogen / Q000187:drug effects; D013329:Structure-Activity Relationship; D013629:Tamoxifen / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
D004965:Estrogen Antagonists; D004967:Estrogens; D006133:Growth Substances; D011960:Receptors, Estrogen; D013629:Tamoxifen